ID   CCL2_RAT                Reviewed;         148 AA.
AC   P14844; Q549R5;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=C-C motif chemokine 2;
DE   AltName: Full=Immediate-early serum-responsive protein JE;
DE   AltName: Full=Monocyte chemoattractant protein 1;
DE   AltName: Full=Monocyte chemotactic protein 1;
DE            Short=MCP-1;
DE   AltName: Full=Small-inducible cytokine A2;
DE   Flags: Precursor;
GN   Name=Ccl2; Synonyms=Je, Mcp1, Scya2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=WAG/RIJ; TISSUE=Kidney;
RX   PubMed=2106664; DOI=10.1093/nar/18.1.23;
RA   Timmers H.T.M., Pronk G.J., Bos J.L., van der Eb A.J.;
RT   "Analysis of the rat JE gene promoter identifies an AP-1 binding site
RT   essential for basal expression but not for TPA induction.";
RL   Nucleic Acids Res. 18:23-34(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1704226; DOI=10.1016/0006-291x(91)91445-i;
RA   Yoshimura T., Takeya M., Takahashi K.;
RT   "Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and
RT   its expression in rat spleen cells and tumor cell lines.";
RL   Biochem. Biophys. Res. Commun. 174:504-509(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Aortic smooth muscle;
RA   Poon M., Taubman M.B.;
RT   "Cloning of the full-length rat JE/MCP-1 cDNA.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBCELLULAR LOCATION, AND INDUCTION BY ENDOCANNABINOID ANANDAMIDE AND IL1B.
RX   PubMed=23955712; DOI=10.1038/nm.3265;
RA   Jourdan T., Godlewski G., Cinar R., Bertola A., Szanda G., Liu J., Tam J.,
RA   Han T., Mukhopadhyay B., Skarulis M.C., Ju C., Aouadi M., Czech M.P.,
RA   Kunos G.;
RT   "Activation of the Nlrp3 inflammasome in infiltrating macrophages by
RT   endocannabinoids mediates beta cell loss in type 2 diabetes.";
RL   Nat. Med. 19:1132-1140(2013).
CC   -!- FUNCTION: Acts as a ligand for C-C chemokine receptor CCR2 (By
CC       similarity). Signals through binding and activation of CCR2 and induces
CC       a strong chemotactic response and mobilization of intracellular calcium
CC       ions (By similarity). Exhibits a chemotactic activity for monocytes and
CC       basophils but not neutrophils or eosinophils (By similarity). Plays an
CC       important role in mediating peripheral nerve injury-induced neuropathic
CC       pain (By similarity). Increases NMDA-mediated synaptic transmission in
CC       both dopamine D1 and D2 receptor-containing neurons, which may be
CC       caused by MAPK/ERK-dependent phosphorylation of GRIN2B/NMDAR2B (By
CC       similarity). {ECO:0000250|UniProtKB:P10148,
CC       ECO:0000250|UniProtKB:P13500}.
CC   -!- SUBUNIT: Monomer or homodimer; in equilibrium. Is tethered on
CC       endothelial cells by glycosaminoglycan (GAG) side chains of
CC       proteoglycans. Interacts with TNFAIP6 (via Link domain).
CC       {ECO:0000250|UniProtKB:P13500}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:23955712}.
CC   -!- INDUCTION: In pancreatic islets, secretion is stimulated by IL1B
CC       (PubMed:23955712). In islets from Zucker diabetic fatty (ZDF) rats, but
CC       not lean animals, secretion is also increased by endocannabinoid
CC       anandamide/AEA (PubMed:23955712). {ECO:0000269|PubMed:23955712}.
CC   -!- PTM: Processing at the N-terminus can regulate receptor and target cell
CC       selectivity (By similarity). Deletion of the N-terminal residue
CC       converts it from an activator of basophil to an eosinophil
CC       chemoattractant (By similarity). {ECO:0000250|UniProtKB:P13500}.
CC   -!- PTM: N-Glycosylated. {ECO:0000250|UniProtKB:P13500}.
CC   -!- SIMILARITY: Belongs to the intercrine beta (chemokine CC) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17053; CAA34901.1; -; Genomic_DNA.
DR   EMBL; M57441; AAA63496.1; -; mRNA.
DR   EMBL; AF058786; AAC15187.1; -; mRNA.
DR   PIR; S07723; S07723.
DR   RefSeq; NP_113718.1; NM_031530.1.
DR   AlphaFoldDB; P14844; -.
DR   SMR; P14844; -.
DR   STRING; 10116.ENSRNOP00000009448; -.
DR   GlyCosmos; P14844; 1 site, No reported glycans.
DR   GlyGen; P14844; 1 site.
DR   PhosphoSitePlus; P14844; -.
DR   PaxDb; 10116-ENSRNOP00000009448; -.
DR   Ensembl; ENSRNOT00000009448.4; ENSRNOP00000009448.1; ENSRNOG00000007159.4.
DR   Ensembl; ENSRNOT00055044192; ENSRNOP00055036150; ENSRNOG00055025618.
DR   Ensembl; ENSRNOT00060033398; ENSRNOP00060027325; ENSRNOG00060019323.
DR   Ensembl; ENSRNOT00065032989; ENSRNOP00065026364; ENSRNOG00065019591.
DR   GeneID; 24770; -.
DR   KEGG; rno:24770; -.
DR   AGR; RGD:3645; -.
DR   CTD; 6347; -.
DR   RGD; 3645; Ccl2.
DR   eggNOG; ENOG502S6ZP; Eukaryota.
DR   GeneTree; ENSGT01100000263482; -.
DR   HOGENOM; CLU_141716_1_0_1; -.
DR   InParanoid; P14844; -.
DR   OMA; PLTCCYS; -.
DR   OrthoDB; 4265193at2759; -.
DR   PhylomeDB; P14844; -.
DR   TreeFam; TF339372; -.
DR   PRO; PR:P14844; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000007159; Expressed in stomach and 16 other cell types or tissues.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044299; C:C-fiber; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:RGD.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0048020; F:CCR chemokine receptor binding; IBA:GO_Central.
DR   GO; GO:0031727; F:CCR2 chemokine receptor binding; ISO:RGD.
DR   GO; GO:0008009; F:chemokine activity; IDA:RGD.
DR   GO; GO:0005125; F:cytokine activity; ISO:RGD.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; IPI:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IBA:GO_Central.
DR   GO; GO:0043615; P:astrocyte cell migration; ISO:RGD.
DR   GO; GO:0071318; P:cellular response to ATP; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071403; P:cellular response to high density lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071354; P:cellular response to interleukin-6; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071402; P:cellular response to lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IMP:RGD.
DR   GO; GO:0042466; P:chemokinesis; TAS:RGD.
DR   GO; GO:0002544; P:chronic inflammatory response; IEP:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:RGD.
DR   GO; GO:0007010; P:cytoskeleton organization; ISO:RGD.
DR   GO; GO:0048245; P:eosinophil chemotaxis; IBA:GO_Central.
DR   GO; GO:0008347; P:glial cell migration; IMP:RGD.
DR   GO; GO:0035684; P:helper T cell extravasation; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IDA:RGD.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; IMP:RGD.
DR   GO; GO:0048247; P:lymphocyte chemotaxis; IDA:RGD.
DR   GO; GO:0048246; P:macrophage chemotaxis; IDA:RGD.
DR   GO; GO:0060056; P:mammary gland involution; IEP:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEP:RGD.
DR   GO; GO:0060137; P:maternal process involved in parturition; IEP:RGD.
DR   GO; GO:0002548; P:monocyte chemotaxis; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; ISO:RGD.
DR   GO; GO:2000502; P:negative regulation of natural killer cell chemotaxis; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:1905563; P:negative regulation of vascular endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IMP:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; HEP:RGD.
DR   GO; GO:2000427; P:positive regulation of apoptotic cell clearance; ISO:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISO:RGD.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IDA:RGD.
DR   GO; GO:0002693; P:positive regulation of cellular extravasation; IDA:RGD.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:RGD.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0090265; P:positive regulation of immune complex clearance by monocytes and macrophages; ISO:RGD.
DR   GO; GO:0001912; P:positive regulation of leukocyte mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IDA:RGD.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; IDA:RGD.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISO:RGD.
DR   GO; GO:1904783; P:positive regulation of NMDA glutamate receptor activity; IGI:ARUK-UCL.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IDA:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:UniProtKB.
DR   GO; GO:0050870; P:positive regulation of T cell activation; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:0090303; P:positive regulation of wound healing; IMP:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0010574; P:regulation of vascular endothelial growth factor production; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   GO; GO:1905237; P:response to cyclosporin A; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0010332; P:response to gamma radiation; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0035900; P:response to isolation stress; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0033552; P:response to vitamin B3; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:RGD.
DR   CDD; cd00272; Chemokine_CC; 1.
DR   Gene3D; 2.40.50.40; -; 1.
DR   InterPro; IPR039809; Chemokine_b/g/d.
DR   InterPro; IPR000827; Chemokine_CC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   InterPro; IPR036048; Interleukin_8-like_sf.
DR   PANTHER; PTHR12015:SF117; C-C MOTIF CHEMOKINE 2; 1.
DR   PANTHER; PTHR12015; SMALL INDUCIBLE CYTOKINE A; 1.
DR   Pfam; PF00048; IL8; 1.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; Interleukin 8-like chemokines; 1.
DR   PROSITE; PS00472; SMALL_CYTOKINES_CC; 1.
PE   2: Evidence at transcript level;
KW   Chemotaxis; Cytokine; Disulfide bond; Glycoprotein; Inflammatory response;
KW   Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000250"
FT   CHAIN           24..148
FT                   /note="C-C motif chemokine 2"
FT                   /id="PRO_0000005151"
FT   MOD_RES         24
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P13500"
FT   CARBOHYD        126
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34..59
FT                   /evidence="ECO:0000250"
FT   DISULFID        35..75
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   148 AA;  16460 MW;  62D4C42BF4B11C9D CRC64;
     MQVSVTLLGL LFTVAACSIH VLSQPDAVNA PLTCCYSFTG KMIPMSRLEN YKRITSSRCP
     KEAVVFVTKL KREICADPNK EWVQKYIRKL DQNQVRSETT VFYKIASTLR TSAPLNVNLT
     HKSEANASTL FSTTTSSTSV EVTSMTEN
//
